The European accreditation of Istituto Tumori Giovanni Paolo II of Bari

Rosanna Lacalamita; Antonio Quaranta; Maria Pia Trisorio Liuzzi; Aldo Nigro; Umberto Simonetti; Massimiliano Schirone; Ferruccio Aloè; Gianluca Capochiani; Genoveffa De Francesco; Cosimo Gadaleta; Domenico Galetta; Luciano Grammatica; Attilio Guarini; Vittorio Mattioli; Piero Milella; Antonio Moschetta; Patrizia Nardulli; Vincenza Nigro; Nico Silvestris; Angelo Paradiso

doi:10.5301/tj.5000467

The European accreditation of Istituto Tumori Giovanni Paolo II of Bari

Rosanna Lacalamita, Antonio Quaranta, Maria Pia Trisorio Liuzzi, Aldo Nigro, Umberto Simonetti, Massimiliano Schirone, Ferruccio Aloè, Gianluca Capochiani, Genoveffa De Francesco, Cosimo Gadaleta, Domenico Galetta, Luciano Grammatica, Attilio Guarini, Vittorio Mattioli, Piero Milella, Antonio Moschetta, Patrizia Nardulli, Vincenza Nigro, Nico Silvestris, Angelo Paradiso

Pharmacology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The National Cancer Institute of Bari (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS) has been involved since the conception of the project of the Italian Ministry for Health aimed to validate the applicability of the Organisation of European Cancer Institutes (OECI) accreditation and designation (A&D) model to the Network of Italian Cancer Centers, IRCCS, of Alleanza Contro il Cancro. The self-assessment phase of the Institute started in September 2013 and ended in June 2014. All documents and tools were transferred to the OECI A&D Board in June 2014 and a 2-day peer review visit was conducted in October 2014 by an international qualified audit team. The Institute received its final designation and certification in June 2015. The OECI A&D Board, in its final report, came to the conclusion that Istituto Tumori "Giovanni Paolo II" of Bari has a strong research component with some essential elements of comprehensive cancer care still under development; the lack of a system for using outcome data for the strategic management approach to decision-making and missing a regular internal audit system eventually helping further quality improvement were reported as examples of areas with opportunities for improvement. The OECI A&D process represented a great opportunity for the cancer center to benchmark the quality of its performance according to standard parameters in comparison with other international centers and to further develop a participatory group identity. The common goal of accreditation was real and participatory with long-lasting positive effects. We agree with the OECI comments about the next areas of work in which the Institute could produce future further efforts: the use of its powerful IT system as a means for outcome analysis and empowerment projects for its cancer patients.

Original language	English (US)
Pages (from-to)	S14-S18
Journal	Tumori
Volume	101
DOIs	https://doi.org/10.5301/tj.5000467
State	Published - Dec 2015

Keywords

Accreditation
Oncology
Outcome
Patient
Quality standard
Research

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.5301/tj.5000467

Cite this

Lacalamita, R., Quaranta, A., Liuzzi, M. P. T., Nigro, A., Simonetti, U., Schirone, M., Aloè, F., Capochiani, G., De Francesco, G., Gadaleta, C., Galetta, D., Grammatica, L., Guarini, A., Mattioli, V., Milella, P., Moschetta, A., Nardulli, P., Nigro, V., Silvestris, N., & Paradiso, A. (2015). The European accreditation of Istituto Tumori Giovanni Paolo II of Bari. Tumori, 101, S14-S18. https://doi.org/10.5301/tj.5000467

Lacalamita, R, Quaranta, A, Liuzzi, MPT, Nigro, A, Simonetti, U, Schirone, M, Aloè, F, Capochiani, G, De Francesco, G, Gadaleta, C, Galetta, D, Grammatica, L, Guarini, A, Mattioli, V, Milella, P, Moschetta, A, Nardulli, P, Nigro, V, Silvestris, N & Paradiso, A 2015, 'The European accreditation of Istituto Tumori Giovanni Paolo II of Bari', Tumori, vol. 101, pp. S14-S18. https://doi.org/10.5301/tj.5000467

@article{ca8ecc0e2a964433b8a7ee05b1f9eae8,

title = "The European accreditation of Istituto Tumori Giovanni Paolo II of Bari",

abstract = "The National Cancer Institute of Bari (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS) has been involved since the conception of the project of the Italian Ministry for Health aimed to validate the applicability of the Organisation of European Cancer Institutes (OECI) accreditation and designation (A&D) model to the Network of Italian Cancer Centers, IRCCS, of Alleanza Contro il Cancro. The self-assessment phase of the Institute started in September 2013 and ended in June 2014. All documents and tools were transferred to the OECI A&D Board in June 2014 and a 2-day peer review visit was conducted in October 2014 by an international qualified audit team. The Institute received its final designation and certification in June 2015. The OECI A&D Board, in its final report, came to the conclusion that Istituto Tumori {"}Giovanni Paolo II{"} of Bari has a strong research component with some essential elements of comprehensive cancer care still under development; the lack of a system for using outcome data for the strategic management approach to decision-making and missing a regular internal audit system eventually helping further quality improvement were reported as examples of areas with opportunities for improvement. The OECI A&D process represented a great opportunity for the cancer center to benchmark the quality of its performance according to standard parameters in comparison with other international centers and to further develop a participatory group identity. The common goal of accreditation was real and participatory with long-lasting positive effects. We agree with the OECI comments about the next areas of work in which the Institute could produce future further efforts: the use of its powerful IT system as a means for outcome analysis and empowerment projects for its cancer patients.",

keywords = "Accreditation, Oncology, Outcome, Patient, Quality standard, Research",

author = "Rosanna Lacalamita and Antonio Quaranta and Liuzzi, {Maria Pia Trisorio} and Aldo Nigro and Umberto Simonetti and Massimiliano Schirone and Ferruccio Alo{\`e} and Gianluca Capochiani and {De Francesco}, Genoveffa and Cosimo Gadaleta and Domenico Galetta and Luciano Grammatica and Attilio Guarini and Vittorio Mattioli and Piero Milella and Antonio Moschetta and Patrizia Nardulli and Vincenza Nigro and Nico Silvestris and Angelo Paradiso",

note = "Publisher Copyright: {\textcopyright} 2015 INTM.",

year = "2015",

month = dec,

doi = "10.5301/tj.5000467",

language = "English (US)",

volume = "101",

pages = "S14--S18",

journal = "Tumori",

issn = "0300-8916",

publisher = "Wichtig Publishing",

}

TY - JOUR

T1 - The European accreditation of Istituto Tumori Giovanni Paolo II of Bari

AU - Lacalamita, Rosanna

AU - Quaranta, Antonio

AU - Liuzzi, Maria Pia Trisorio

AU - Nigro, Aldo

AU - Simonetti, Umberto

AU - Schirone, Massimiliano

AU - Aloè, Ferruccio

AU - Capochiani, Gianluca

AU - De Francesco, Genoveffa

AU - Gadaleta, Cosimo

AU - Galetta, Domenico

AU - Grammatica, Luciano

AU - Guarini, Attilio

AU - Mattioli, Vittorio

AU - Milella, Piero

AU - Moschetta, Antonio

AU - Nardulli, Patrizia

AU - Nigro, Vincenza

AU - Silvestris, Nico

AU - Paradiso, Angelo

PY - 2015/12

Y1 - 2015/12

N2 - The National Cancer Institute of Bari (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS) has been involved since the conception of the project of the Italian Ministry for Health aimed to validate the applicability of the Organisation of European Cancer Institutes (OECI) accreditation and designation (A&D) model to the Network of Italian Cancer Centers, IRCCS, of Alleanza Contro il Cancro. The self-assessment phase of the Institute started in September 2013 and ended in June 2014. All documents and tools were transferred to the OECI A&D Board in June 2014 and a 2-day peer review visit was conducted in October 2014 by an international qualified audit team. The Institute received its final designation and certification in June 2015. The OECI A&D Board, in its final report, came to the conclusion that Istituto Tumori "Giovanni Paolo II" of Bari has a strong research component with some essential elements of comprehensive cancer care still under development; the lack of a system for using outcome data for the strategic management approach to decision-making and missing a regular internal audit system eventually helping further quality improvement were reported as examples of areas with opportunities for improvement. The OECI A&D process represented a great opportunity for the cancer center to benchmark the quality of its performance according to standard parameters in comparison with other international centers and to further develop a participatory group identity. The common goal of accreditation was real and participatory with long-lasting positive effects. We agree with the OECI comments about the next areas of work in which the Institute could produce future further efforts: the use of its powerful IT system as a means for outcome analysis and empowerment projects for its cancer patients.

AB - The National Cancer Institute of Bari (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS) has been involved since the conception of the project of the Italian Ministry for Health aimed to validate the applicability of the Organisation of European Cancer Institutes (OECI) accreditation and designation (A&D) model to the Network of Italian Cancer Centers, IRCCS, of Alleanza Contro il Cancro. The self-assessment phase of the Institute started in September 2013 and ended in June 2014. All documents and tools were transferred to the OECI A&D Board in June 2014 and a 2-day peer review visit was conducted in October 2014 by an international qualified audit team. The Institute received its final designation and certification in June 2015. The OECI A&D Board, in its final report, came to the conclusion that Istituto Tumori "Giovanni Paolo II" of Bari has a strong research component with some essential elements of comprehensive cancer care still under development; the lack of a system for using outcome data for the strategic management approach to decision-making and missing a regular internal audit system eventually helping further quality improvement were reported as examples of areas with opportunities for improvement. The OECI A&D process represented a great opportunity for the cancer center to benchmark the quality of its performance according to standard parameters in comparison with other international centers and to further develop a participatory group identity. The common goal of accreditation was real and participatory with long-lasting positive effects. We agree with the OECI comments about the next areas of work in which the Institute could produce future further efforts: the use of its powerful IT system as a means for outcome analysis and empowerment projects for its cancer patients.

KW - Accreditation

KW - Oncology

KW - Outcome

KW - Patient

KW - Quality standard

KW - Research

UR - http://www.scopus.com/inward/record.url?scp=84958630098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958630098&partnerID=8YFLogxK

U2 - 10.5301/tj.5000467

DO - 10.5301/tj.5000467

M3 - Article

C2 - 27096266

AN - SCOPUS:84958630098

SN - 0300-8916

VL - 101

SP - S14-S18

JO - Tumori

JF - Tumori

ER -

The European accreditation of Istituto Tumori Giovanni Paolo II of Bari

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this